retatrutide triple agonist Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset Retatrutide - Wikipedia

Though peptides in general are gaining traction across a range of therapeutic frontiers, from rare diseases to neurodegenerative conditions such as Alzheimers, the rise of GLP-1s as a blockbuster therapy for chronic weight management has redefined the field of peptide manufacturing

Retatrutide is the next-generation triple agonist that consistently outperforms Tirzepatide in Phase 2 weight loss data through its additional glucagon receptor pathway, but awaits Phase 3 validation

doi: 10.1016/j.obpill.2025.100209 3

Stimulating GLP-1 Production Through Diet Studies of the Mediterranean diet show that the combination of lean protein, healthy fats, and dietary fiber-rich foods stimulate high levels of GLP-1 after meals (compared to a high-fiber vegetarian diet) 6

GLP-1 receptor agonists do not directly alter renal electrolyte handling in a way that causes predictable deficiency

Genetic variants can affect the response to GLP-1 agonists for weight loss